济南中途疲软怎么办(济南射精没有力如何治疗) (今日更新中)

DOHA, Jan. 18 (Xinhua) -- Visiting Chinese Premier Wen Jiabao said here Wednesday that the Strait of Hormuz should be kept open under all circumstances and Beijing opposes "any extreme acts" at the strategic passageway."Any extreme acts across the Strait of Hormuz, under whatever circumstances they are taken, are against the common interests and aspiration of the people across the world," Wen told a press conference during his official visit to Qatar.The Chinese premier said that cargo transportation through the strait should be protected because it concerns the interests of the whole humanity.Chinese Premier Wen Jiabao attends a press conference in Doha, capital of Qatar, Jan. 18, 2012.China maintains that the Iranian nuclear issue should be resolved through peaceful means, he said, adding that Beijing supports the political process between Iran and the Iran Six, a diplomatic group made up of the United States, China, Russia, Britain, France and Germany.China firmly opposes Iran producing and possessing nuclear weapons and will work with concerned parties to establish a nuclear-free Middle East, Wen said, while stressing that China will not trade its principles for profits.However, just like many other countries, China has also kept "normal" and "justified" trade with Iran, which should be protected, Wen said, adding that should normal trade not be protected, the normal international order would be disturbed."I am not worried about the the normal trade between China and Iran at all," Wen told reporters.Wen arrived in Doha on Wednesday morning after concluding an official visit to the United Arab Emirates.

WASHINGTON, Dec. 21 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Wednesday approved Isentress for the treatment of HIV-1 infection for children and adolescents.The drug is part of a class of medications called HIV integrase strand transfer inhibitors that works by slowing the spread of HIV in the body. It was first approved for use in adult patients in October 2007, under FDA's accelerated approval program."Many young children and adolescents are living with HIV and this approval provides an important additional option for their treatment," said Edward Cox, director of the Office of Antimicrobial Products in the FDA's Center for Drug Evaluation and Research.Isentress is a pill that can be taken twice daily, with or without food. The pill is also available in a chewable form. As the two tablet formulations are not interchangeable, the chewable form is only approved for use in children ages 2 to 11.A single, multi-center clinical trial of 96 children and adolescents aged 2-18 years with HIV-1 infection evaluated the safety and effectiveness of Isentress. These patients previously received treatment for HIV-1 infection. After 24 weeks of treatment with Isentress, 53 percent of these patients had an undetectable amount of HIV in their blood.According to the FDA, the most commonly reported severe, treatment-related side effects in patients taking Isentress include trouble sleeping and headache. The frequency of these side effects is similar for children and adults. One pediatric patient reported severe treatment-related insomnia, while another pediatric patient experienced a drug-related skin rash.

BEIJING, Oct. 11 (Xinhuanet) -- An experimental drug that can remove amyloid plaques from the brains of Alzheimer's patients is being developed by Swiss Roche Holding AG in a small early-stage study, according to a report published in the Archives of Neurology on Monday.Researchers suspect the build-up of such plaques may be a cause of the memory robbing disease, although that theory has yet to be definitively proved. Gantenerumab, a biotech drug designed to bind to amyloid plaques in the brain and remove them, is being targeted at the early stages of Alzheimer's with the hope it can slow progression of the disease while patients are still able to function.The Phase I study of 16 Alzheimer's patients tested gantenerumab at two doses against a placebo over six months of treatment.The Roche drug led to a dose-dependent reduction of brain amyloid, while amyloid load increased in patients receiving a placebo, the report said.The next step will be to investigate whether removal of brain amyloid translates into clinical benefit for patients at doses of the experimental drug that are well tolerated and safe, the report said.Much larger trials and further study will be needed to fully understand how gantenerumab works and whether it can stave off Alzheimer's, said the report.Roche is approaching the disease far earlier because amyloid accumulates for 15 years before dementi.

WASHINGTON, Nov. 16 (Xinhua) -- Data from NASA's Galileo spacecraft have provided scientists evidence of what appears to be a body of liquid water, equal in volume to the North American Great Lakes, beneath the icy surface of Jupiter's moon, Europa, the U.S. space agency announced Wednesday.The data suggest there is significant exchange between Europa's icy shell and the ocean beneath. This information could bolster arguments that Europa's global subsurface ocean represents a potential habitat for life elsewhere in our solar system. The findings will be published Thursday in the scientific journal Nature.Europa, which is slightly smaller than Earth's moon, is believed to have a large ocean of salty water deep beneath its frozen crust. Galileo spacecraft, launched by the space shuttle Atlantis in 1989, studied Jupiter, which is the most massive planet in the solar system, and some of its many moons.Pictures of it sent back by Galileo point to a tortured surface of cracks and jumbled ice. Seeking to understand how such weird topography evolved in a place with such dim sunlight, scientists believe that the answer lies in similar processes on Earth.Their model suggests that Europa's ice shell is about 10 kilometers thick and within it are giant pockets of water, lying at depths as shallow as three kilometers. Warm water from these sub-surface lakes wells up in plumes, causing the ice to become brittle, crack and then collapse. The ice turnover would be a plus for the prospects for life, as it would transfer energy and nutrients between the sub-glacial lake and the surface."One opinion in the scientific community has been if the ice shell is thick, that's bad for biology. That might mean the surface isn't communicating with the underlying ocean," said Britney Schmidt, lead author of the paper and postdoctoral fellow at the Institute for Geophysics, University of Texas at Austin. " Now, we see evidence that it's a thick ice shell that can mix vigorously and new evidence for giant shallow lakes. That could make Europa and its ocean more habitable.""The data opens up some compelling possibilities," said Mary Voytek, director of NASA's Astrobiology Program. "However, scientists worldwide will want to take a close look at this analysis and review the data before we can fully appreciate the implication of these results."

SHANGHAI, Oct. 14 (Xinhua) -- The government of Shanghai, the largest metropolis in eastern China, plans to require users of matchmaking websites to register their real names, a move to make those websites a more honest and ordered community, authorities said on Friday.The environment of the matchmaking websites is chaotic and the anonymity afforded by the Internet opens the door to cybercrimes such as fraud, said Zhou Juemin, chairperson of Shanghai Matchmaking Organization Administration Association.Officials with the Shanghai Civil Affairs Bureau said people who put up personal ads in newspapers may also be requested to use their real names in the future.China's matchmaking industry has been thriving in recent years as the country is witnessing an increase in the number of singles. Statistics from the All-China Women's Federation shows China currently has around 180 million singles.

来源：资阳报